EdgarLookup

CITIGROUP INC — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that CITIGROUP INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
16.8%
Profit Margin
Net income ÷ revenue
0.5%
Return on Assets
Net income ÷ assets
11.51x
Debt-to-Equity
Total liabilities ÷ equity
+5.6%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $85.23B Feb 20, 2026
FY2025 Dec 31, 2024 $80.72B Feb 20, 2026
FY2025 Dec 31, 2023 $78.07B Feb 20, 2026
FY2024 Dec 31, 2022 $75.34B Feb 21, 2025
FY2021 Dec 31, 2021 $17.02B Feb 28, 2022
FY2021 Sep 30, 2021 $17.45B Feb 28, 2022
FY2021 Jun 30, 2021 $17.75B Feb 28, 2022
FY2021 Mar 31, 2021 $19.67B Feb 28, 2022
FY2021 Dec 31, 2020 $16.83B Feb 28, 2022
FY2021 Sep 30, 2020 $17.68B Feb 28, 2022

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $14.31B Feb 20, 2026
FY2025 Dec 31, 2024 $12.68B Feb 20, 2026
FY2025 Dec 31, 2023 $9.23B Feb 20, 2026
FY2024 Dec 31, 2022 $14.85B Feb 21, 2025
FY2021 Dec 31, 2021 $3.17B Feb 28, 2022
FY2021 Sep 30, 2021 $4.64B Feb 28, 2022
FY2021 Jun 30, 2021 $6.19B Feb 28, 2022
FY2021 Mar 31, 2021 $7.94B Feb 28, 2022
FY2021 Dec 31, 2020 $4.31B Feb 28, 2022
FY2021 Sep 30, 2020 $3.15B Feb 28, 2022

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($67.63B) Feb 20, 2026
FY2025 Dec 31, 2024 ($19.67B) Feb 20, 2026
FY2025 Dec 31, 2023 ($73.42B) Feb 20, 2026
FY2024 Dec 31, 2022 $25.07B Feb 21, 2025
FY2023 Dec 31, 2021 $47.09B Feb 23, 2024
FY2022 Dec 31, 2020 ($23.49B) Feb 27, 2023
FY2021 Dec 31, 2019 ($12.84B) Feb 28, 2022
FY2020 Dec 31, 2018 $36.95B Feb 26, 2021

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $6.52B Feb 20, 2026
FY2025 Dec 31, 2024 $6.50B Feb 20, 2026
FY2025 Dec 31, 2023 $6.58B Feb 20, 2026
FY2024 Dec 31, 2022 $5.63B Feb 21, 2025
FY2023 Dec 31, 2021 $4.12B Feb 23, 2024
FY2022 Dec 31, 2020 $3.45B Feb 27, 2023
FY2021 Dec 31, 2019 $5.34B Feb 28, 2022
FY2020 Dec 31, 2018 $3.77B Feb 26, 2021
FY2019 Dec 31, 2017 $3.36B Feb 21, 2020
FY2018 Dec 31, 2016 $2.76B Feb 22, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2,657.20B Feb 20, 2026
FY2025 Dec 31, 2024 $2,352.95B Feb 20, 2026
FY2025 Dec 31, 2023 $2,412.00B Feb 20, 2026
FY2024 Dec 31, 2022 $2,417.00B Feb 21, 2025
FY2023 Dec 31, 2021 $2,291.00B Feb 23, 2024
FY2022 Dec 31, 2020 $2,260.00B Feb 27, 2023
FY2020 Dec 31, 2019 $1,951.16B Feb 26, 2021
FY2019 Dec 31, 2018 $1,917.38B Feb 21, 2020
FY2018 Dec 31, 2017 $1,842.47B Feb 22, 2019
FY2017 Dec 31, 2016 $1,792.08B Feb 23, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2,443.38B Feb 20, 2026
FY2025 Dec 31, 2024 $2,143.58B Feb 20, 2026
FY2024 Dec 31, 2023 $2,205.58B Feb 21, 2025
FY2023 Dec 31, 2022 $2,214.84B Feb 23, 2024
FY2022 Dec 31, 2021 $2,088.74B Feb 27, 2023
FY2021 Dec 31, 2020 $2,059.89B Feb 28, 2022
FY2020 Dec 31, 2019 $1,757.21B Feb 26, 2021
FY2019 Dec 31, 2018 $1,720.31B Feb 21, 2020
FY2018 Dec 31, 2017 $1,640.79B Feb 22, 2019
FY2017 Dec 31, 2016 $1,565.93B Feb 23, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $212.29B Feb 20, 2026
FY2025 Dec 31, 2024 $208.60B Feb 20, 2026
FY2024 Dec 31, 2023 $205.45B Feb 21, 2025
FY2023 Dec 31, 2022 $201.19B Feb 23, 2024
FY2022 Dec 31, 2021 $201.97B Feb 27, 2023
FY2021 Dec 31, 2020 $199.44B Feb 28, 2022
FY2020 Dec 31, 2019 $193.24B Feb 26, 2021
FY2019 Dec 31, 2018 $196.22B Feb 21, 2020
FY2018 Dec 31, 2017 $200.74B Feb 22, 2019
FY2017 Dec 31, 2016 $225.12B Feb 23, 2018

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $19.10B Feb 20, 2026
FY2025 Dec 31, 2024 $19.30B Feb 20, 2026
FY2025 Dec 31, 2023 $20.10B Feb 20, 2026
FY2025 Dec 31, 2022 $19.69B Feb 20, 2026
FY2024 Dec 31, 2021 $21.30B Feb 21, 2025
FY2023 Dec 31, 2020 $22.16B Feb 23, 2024
FY2022 Dec 31, 2019 $22.13B Feb 27, 2023
FY2021 Dec 31, 2018 $22.05B Feb 28, 2022
FY2020 Dec 31, 2017 $22.26B Feb 26, 2021
FY2019 Dec 31, 2016 $21.66B Feb 21, 2020

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $215.13B Feb 20, 2026
FY2025 Dec 31, 2024 $206.29B Feb 20, 2026
FY2024 Dec 31, 2023 $198.91B Feb 21, 2025
FY2023 Dec 31, 2022 $194.73B Feb 23, 2024
FY2022 Dec 31, 2021 $184.95B Feb 27, 2023
FY2021 Dec 31, 2020 $168.27B Feb 28, 2022
FY2020 Dec 31, 2019 $165.37B Feb 26, 2021
FY2019 Dec 31, 2018 $151.35B Feb 21, 2020
FY2018 Dec 31, 2017 $138.43B Feb 22, 2019
FY2017 Dec 31, 2016 $146.48B Feb 23, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2018 Dec 31, 2018 $188.11B Feb 22, 2019
FY2018 Dec 31, 2017 $180.52B Feb 22, 2019
FY2018 Dec 31, 2016 $160.49B Feb 22, 2019
FY2018 Dec 31, 2015 $133.10B Feb 22, 2019

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $315.83B Feb 20, 2026
FY2025 Dec 31, 2024 $287.30B Feb 20, 2026
FY2024 Dec 31, 2023 $286.62B Feb 21, 2025
FY2023 Dec 31, 2022 $271.61B Feb 23, 2024
FY2022 Dec 31, 2021 $254.37B Feb 27, 2023
FY2021 Dec 31, 2020 $271.69B Feb 28, 2022
FY2020 Dec 31, 2019 $248.76B Feb 26, 2021
FY2019 Dec 31, 2018 $232.00B Feb 21, 2020
FY2018 Dec 31, 2017 $236.71B Feb 22, 2019
FY2017 Dec 31, 2016 $206.18B Feb 23, 2018

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 7 Feb 20, 2026
FY2025 Dec 31, 2024 6 Feb 20, 2026
FY2025 Dec 31, 2023 4 Feb 20, 2026
FY2024 Dec 31, 2022 7 Feb 21, 2025
FY2021 Dec 31, 2021 1 Feb 28, 2022
FY2021 Sep 30, 2021 2 Feb 28, 2022
FY2021 Jun 30, 2021 2 Feb 28, 2022
FY2021 Mar 31, 2021 3 Feb 28, 2022
FY2021 Dec 31, 2020 1 Feb 28, 2022
FY2021 Sep 30, 2020 1 Feb 28, 2022

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 6 Feb 20, 2026
FY2025 Dec 31, 2024 5 Feb 20, 2026
FY2025 Dec 31, 2023 4 Feb 20, 2026
FY2024 Dec 31, 2022 7 Feb 21, 2025
FY2021 Dec 31, 2021 1 Feb 28, 2022
FY2021 Sep 30, 2021 2 Feb 28, 2022
FY2021 Jun 30, 2021 2 Feb 28, 2022
FY2021 Mar 31, 2021 3 Feb 28, 2022
FY2021 Dec 31, 2020 1 Feb 28, 2022
FY2021 Sep 30, 2020 1 Feb 28, 2022